Better Evidence. Better Decisions. Better Health: Payer Perspectives
An Academy Health Webinar
Payers are in a unique perspective to drive the use of evidence in practice. Whether through coverage decisions, utilization review, or coinsurance, there are many strategies payers use to reflect the value of specific therapies within the marketplace. So, what information do payers feel they need to guide these efforts? Raj Sabharwal, M.P.H., Director at AcademyHealth will discuss his article “Developing Evidence That Is Fit for Purpose: A Framework for Payer and Research Dialogue,” which describes efforts to develop and refine a decision-making framework that considers payers’ perspectives on the utility of evidence generated by different types of research methods, including real-world evidence. Panelists from the National Pharmaceutical Council and AcademyHealth’s Corporate Council and will provide insight into the decision-making framework and will provide perspectives from their own institutions.
During this webinar, participants will:
- Understand the “Fit for Purpose” framework for payer and research dialogue;
- Discuss conditions under which more evidence is needed, and perspectives on the type of evidence needed to meet this demand;
- Identify techniques to engage multiple stakeholder groups in developing real-world evidence that can support decision-making.
Speaker: Raj Sabharwal, MPH, Director at AcademyHealth
Reactors: Jennifer Graff, PharmD, Vice President of Comparative Effectiveness Research at the National Pharmaceutical Council (NPC)
Link to the webinar series on Academy HealthThe EDM Forum webinar series Better Evidence. Better Decisions. Better Health. will share tools and methods being developed and used in learning health systems to address challenges in achieving better patient care. A series of ‘upstream’ uses of lessons learned from patient-centered outcomes research (PCOR) will be featured, including approaches to develop and test e-Clinical Quality Measures (eCQMs), clinical decision support (CDS), and evaluate the evidentiary needs of payers and purchasers.